The company, a venture on R&D of iPS cell-derived cartilage, which was formed just 10 months ago, decided during an extraordinary shareholders’ meeting to dissolve.
Nikkei Biotech news release, February 10, 2016
The company, a venture on R&D of iPS cell-derived cartilage, which was formed just 10 months ago, decided during an extraordinary shareholders’ meeting to dissolve.
Nikkei Biotech news release, February 10, 2016
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.
Accept or Deny